Under pathologic circumstances, dysfunctional BMP signaling (often compromised by BMPR2 gene mutations) weakens its homeostatic role on the pulmonary vasculature, and increased VEGF signaling activity promotes dysregulated angiogenesis in the context of PAH. The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.